Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-04-25
2010-11-23
Canella, Karen A (Department: 1643)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S021800, C514S04400A, C530S350000, C424S093200
Reexamination Certificate
active
07838495
ABSTRACT:
Inhibition of the proliferation of hormone refractory prostate cancer cells is achieved by administering EPB1, an ErbB3 binding protein, in combination with another anti-proliferation therapy such as administration of antiandrogens, other anticancer agents, radiation therapy, or surgery. Administration of EPB1 reverses the phenotype of hormone-resistant prostate cancer cells to hormone-sensitive prostate cancer cells.
REFERENCES:
patent: 6080728 (2000-06-01), Mixson
patent: 7247700 (2007-07-01), Korsmeyer et al.
NCBI information page (downloaded from the web on Sep. 28, 2009).
Lessor et al ((Journal of Cellular Physiology, 2000, vol. 183, pp. 321-329).
Zhang and Hamburger (British Journal of Cancer, 2005, vol. 92, pp. 140-146).
Arlen and Gulley (Future Oncology, 2005, vol. 1, pp. 19-22).
Iyer et al (Human Gene Therapy, Jan. 2006, vol. 17, pp. 125-132).
Zhang et al (PNAS, 2005, vol. 102, pp. 9890-9895).
Vargas et al (Prostate Cancer and Prostatic Diseases, 2006, vol. 9, pp. 245-253).
Abrahamsson et al (European Urology, 2005, vol. 48, pp. 900-905).
Zhang et al (Nucleic Acids Research, 2003, vol. 31, pp. 2168-2177).
Hamburger Anne
Zhang Yuexing
Canella Karen A
University of Maryland Baltimore
Whitham Curtis Christofferson & Cook, P.C.
LandOfFree
Compositions and methods of use of EPB1, and ErbB3 binding... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods of use of EPB1, and ErbB3 binding..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods of use of EPB1, and ErbB3 binding... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4187185